Explore our core natural ingredients sourced, analyzed, and optimized for global pharmaceutical and nutraceutical integrations.
An executive analysis of diallyl thiosulfinate chemistry, therapeutic efficacy, and historic validation.
Allicin is the primary biologically active organosulfur compound derived from garlic (Allium sativum). Under physiological conditions within the intact garlic clove, allicin does not exist. It is synthesized instanter when the enzyme alliinase comes into contact with the substrate alliin (S-allyl-L-cysteine sulfoxide) upon mechanical disruption—crushing, cutting, or processing of the plant tissue. This transient defense mechanism generates allicin, which exhibits broad-spectrum antimicrobial, cardiovascular, and immunomodulatory properties.
However, from a pharmaceutical manufacturing standpoint, allicin presents extreme formulation challenges. Its highly volatile, reactive, and heat-sensitive nature causes it to degrade rapidly into secondary organosulfur molecules, such as diallyl disulfide (DADS) and diallyl trisulfide (DATS). Establishing high-purity, standardized allicin preparations that survive gastric transit and deliver predictable therapeutic doses to systemic circulation is the pinnacle of modern phyto-pharmaceutical engineering.
Modern clinical research focuses on the molecular mechanisms of allicin. Key observations indicate that allicin readily crosses cell membranes due to its hydrophobic nature and reacts instantly with cellular thiols (such as glutathione and cysteine residues in proteins) through thiol-disulfide exchange. This specific mechanism underlies its ability to inhibit key enzymes involved in cholesterol biosynthesis (HMG-CoA reductase) and bacterial replication (RNA polymerase), establishing it as a potent natural agent against cardiovascular disease, hypertension, and drug-resistant bacterial strains.
Solving the stabilization bottleneck and driving therapeutic innovations for the next decade.
The primary barrier to maximizing allicin's clinical utility is its inherent instability. To address this, Chengdu Chenlv Herb's R&D division, alongside global research consortia, is executing a technical roadmap that spans stabilization kinetics, novel delivery systems, and synthetic analog development.
Looking Forward: Over the next five to ten years, clinical development will likely expand into oncological adjuvant therapies (specifically targeting gastrointestinal malignancies) and veterinary health as a non-antibiotic growth promoter. Standardized allicin formulas will serve as key components in the global combat against antimicrobial resistance (AMR), providing clean-label therapeutic interventions backed by rigorous chemical profiling.
How the demands of pharmaceutical, functional food, and veterinary sectors shape the natural organosulfur market.
The demand for high-purity botanical extract ingredients like Allicin has witnessed exponential growth. Globally, consumers and regulatory bodies are steering away from synthetic additives, creating a multi-billion dollar market for natural therapeutic agents.
In North America and Europe, the focus remains primarily on cardiovascular health and immune system regulation. The dietary supplement market demands highly standardized alliin and allicin potentials, usually measured via HPLC, to verify therapeutic potency. Meanwhile, in the Asia-Pacific region, the integration of traditional natural products with modern pharmaceutical standards has led to massive commercialization of garlic-based OTC drugs and functional clinical nutrition products.
In the agricultural and animal nutrition sectors, the ban on sub-therapeutic antibiotics (AGPs) in the European Union and parts of North America and Asia has created an urgent need for natural antimicrobials. Allicin preparations have emerged as leading candidates, dramatically reducing pathogens like Salmonella and E. coli in poultry and swine populations without inducing bacterial resistance.
Chengdu ChenLv Herb Co.,Ltd. (referred to as "Chenlv Herb") was established in 2012 as a high-tech enterprise specializing in the R&D, production, and sales of botanical extracts and natural pharmaceutical ingredients. Committed to providing high-purity, highly active, and premium-quality natural raw materials, the company serves diverse industries, including pharmaceuticals, health supplements, food, and cosmetics.
Leveraging agricultural abundance, advanced technology, and logistics to guarantee uninterrupted global distribution.
As the world's largest producer of garlic, China controls the primary supply chain for raw garlic cultivation. Chengdu Chenlv Herb's strategic geographical access to extensive agricultural networks ensures the sourcing of premium, high-alliin cultivars. This direct vertical integration mitigates supply chain volatility and ensures that we maintain a highly stable pricing structure for global distributors.
Our state-of-the-art facility utilizes advanced, green-chemistry extraction technologies, including supercritical CO2 extraction and low-temperature vacuum spray drying. These techniques allow us to capture volatile organosulfur compounds without using toxic organic solvents. Our automated processing systems run at highly optimized efficiency levels, minimizing waste and energy footprint while maximizing yields.
Choose Chenlv Herb for products and services that deliver beyond expectations.
Formulating active ingredients to address specific regional market requirements and regulations.
Driven by the concept of "homology of medicine and food" and modern health needs, plant extracts have gradually become the core raw materials for the development of health care products due to their natural, green and safe characteristics.
READ MORE
From herbal formulas recorded in ancient books to modern innovative drugs, plant extracts occupy the prominent position in the pharmaceutical industry due to their natural active ingredients and unique pharmacological effects.
READ MORE
With consumers' pursuit of natural, safe, and sustainable skincare concepts, plant extracts have become a new favorite in the cosmetics industry due to their mildness, versatility, and biocompatibility, bringing new solutions for skin care.
READ MORE
Plant extracts have shown great potential in improving animal health, enhancing production performance and optimizing culture benefits, and are gradually becoming a research hotspot and new favorite in the field of animal nutrition.
READ MOREChenlv Herb provides one-stop contract manufacturing services customized to your scientific parameters.
Communicate directly with customers to determine product specifications, targeted bio-activities, and purity levels.
Provide a transparent proposal quotation based on batch volumes, standardized markers, and specific logistical lines.
Sign formal supply contracts detailing standard operative procedures, confidentiality agreements, and quality standards.
Formulate and test small-scale bench trial samples to confirm chemical stability, active profiles, and dissolution rates.
Upon customer confirmation of samples, schedule production in our state-of-the-art facility under GMP control.
Conduct chemical assays, microbiological testing, and heavy-metal analysis, issuing a detailed Certificate of Analysis (CoA).
Coordinate international customs and deliver premium botanical solutions directly to your pharmaceutical/nutraceutical warehousing facilities.
Our factory processes are certified by ISO9001, ISO22000, HALAL, KOSHER, and FDA, ensuring absolute regulatory compliance.
Scientific resolutions to common queries regarding active organosulfur extracts, formulation stability, and factory sourcing.
Keep up with our industrial developments, market predictions, and clinical exhibition schedules.
Recently, the market price of Citrus aurantium raw materials in China has been on the rise, drawing significant attention from the industry. As the new production season comes to an end and new supplies enter the market, price fluctuations have become a focal point due to supply and demand dynamics and cost considerations.
As a 'calling card' for leading China's pharmaceutical industry onto the global stage, the 23rd China Pharmaceutical Raw Materials Exhibition (CPHI China 2025) will join hands with the 18th China Pharmaceutical Machinery to foster new botanical ingredient discoveries.
Connect with our technical team in person to discuss customized active ingredients extraction protocols, specialized active molecules delivery mechanisms, and robust supply contract configurations.
For inquiries about our products, technical datasheets, or custom pricing lists, please reach out to us. We will get in touch with you within 24 hours.
Contact USBrowse our additional range of highly standardized, natural active components designed for global pharmaceutical manufacturers.
